(October 11, 2023, 1:02 PM EDT) -- KANSAS CITY, Kan. — Pfizer Inc. has agreed to pay $50 million to settle claims that it conspired with others in an attempt to delay entry of generic competitors for the EpiPen epinephrine autoinjector (EAI) into the market, according to a memorandum filed by the plaintiffs’ counsel on Oct. 10....